SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-04-03 15:49
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+17,500 vol
17,500
Filed 2020-04-03 15:47
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$50,750
+35,000 vol
$1.45 each
40,000
Filed 2017-02-27 17:20
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+26,250 vol
Filed 2017-02-27 17:19
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$76,125
+52,500 vol
$1.45 each
Filed 2020-04-01 15:58
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+86,000 vol
188,200
Filed 2020-04-01 15:56
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+86,000 vol
283,983
Filed 2020-04-01 15:54
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+86,000 vol
505,577
Filed 2020-04-01 15:50
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+253,000 vol
528,000
Filed 2020-04-01 15:45
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+587,000 vol
1,563,315
Filed 2020-04-01 15:43
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+587,000 vol
1,037,000
Filed 2020-04-01 15:38
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,335,000 vol
4,194,248
Filed 2019-08-20 09:04
Tx date 2019-08-19
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$3,016
+1,600 vol
$1.89 each
117,500
Filed 2019-08-20 09:04
Tx date 2019-08-19
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$15,876
+8,400 vol
$1.89 each
115,900
Filed 2019-04-15 14:08
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,136
+58,700 vol
$1.28 each
197,983
Filed 2019-04-15 14:06
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$100,096
+78,200 vol
$1.28 each
419,577
Filed 2019-04-15 14:04
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$66,816
+52,200 vol
$1.28 each
102,200
Filed 2019-04-15 14:02
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$96,000
+75,000 vol
$1.28 each
275,000
Filed 2019-04-15 14:00
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$192,000
+150,000 vol
$1.28 each
450,000
Filed 2019-04-15 13:59
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$448,000
+350,000 vol
$1.28 each
976,315
Filed 2019-04-15 13:55
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,277,440
+998,000 vol
$1.28 each
2,859,248
Filed 2018-10-24
Tx date 2018-10-23
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$48,640
+38,000 vol
$1.28 each
38,000
Filed 2018-10-24
Tx date 2018-04-27
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Holder: Ofra Aslan (Control or Direction)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-23
Tx date 2018-10-09
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$50,000
+50,000 vol
$1.00 each
107,500
Filed 2018-10-09
Tx date 2018-10-04
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$200,000
+200,000 vol
$1.00 each
200,000
Filed 2018-10-09
Tx date 2016-07-12
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-09
Tx date 2018-10-05
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-5,709.74
-4,261 vol
$1.34 each
345,340
Filed 2018-10-09
Tx date 2018-10-05
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$9,323
+7,301 vol
$1.28 each
349,601
Filed 2018-10-09
Tx date 2018-10-04
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-64,569.60
-45,600 vol
$1.42 each
342,300
Filed 2018-10-09
Tx date 2018-10-04
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$341,954
+337,900 vol
$1.01 each
387,900
Filed 2018-10-04
Tx date 2018-10-04
$ACST
Acasti Pharma Inc.
Hamilton, James Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$18,500
+10,000 vol
$1.85 each
10,000
Filed 2018-09-25
Tx date 2018-09-21
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2018-09-25
Tx date 2018-09-21
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
Filed 2018-09-24
Tx date 2018-09-21
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-24
Tx date 2018-09-21
$ACST
Acasti Pharma Inc.
Boily, Jean-François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
200,000
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2018-07-04
Tx date 2018-04-27
$ACST
Acasti Pharma Inc.
Olds, Donald John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+365,515 vol
626,315
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
300,000
Filed 2018-07-04
Tx date 2018-06-01
$ACST
Acasti Pharma Inc.
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+906,248 vol
1,861,248
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+80,377 vol
341,377
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+60,283 vol
139,283
Filed 2018-03-20
Tx date 2018-03-17
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options

-50,000 vol
0
Filed 2018-03-20
Tx date 2018-03-17
$ACST
Acasti Pharma Inc.
Crewe, Katherine
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options

-50,000 vol
0
Filed 2017-11-23
Tx date 2017-11-20
$ACST
Acasti Pharma Inc.
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-2,505.09
-1,057 vol
$2.37 each
3,222
Filed 2017-11-23
Tx date 2017-11-20
$ACST
Acasti Pharma Inc.
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-1,452
-600 vol
$2.42 each
4,279
Filed 2017-11-23
Tx date 2017-11-20
$ACST
Acasti Pharma Inc.
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-8,743.20
-3,643 vol
$2.40 each
4,879
Filed 2017-11-23
Tx date 2017-11-20
$ACST
Acasti Pharma Inc.
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-11,400
-5,000 vol
$2.28 each
0
Filed 2017-11-23
Tx date 2017-11-21
$ACST
Acasti Pharma Inc.
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-123,389.59
-51,199 vol
$2.41 each
Filed 2017-11-23
Tx date 2017-11-20
$ACST
Acasti Pharma Inc.
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-123,389.59
-51,199 vol
$2.41 each
0
Filed 2017-11-23
Tx date 2017-08-15
$ACST
Acasti Pharma Inc.
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
51,199
Filed 2017-09-05
Tx date 2017-08-31
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,000
+50,000 vol
$1.60 each
50,000
Filed 2017-09-05
Tx date 2016-07-12
$ACST
Acasti Pharma Inc.
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-05
Tx date 2017-08-31
$ACST
Acasti Pharma Inc.
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$80,000
+50,000 vol
$1.60 each
50,000
Filed 2017-09-05
Tx date 2015-07-14
$ACST
Acasti Pharma Inc.
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-07
$ACST
Acasti Pharma Inc.
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
$-11,500
-1,000 vol
$11.50 each
0
Filed 2017-06-20
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+17,241 vol
17,241
Filed 2017-06-20
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+25,862 vol
Filed 2017-06-20
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$50,000
+34,483 vol
$1.45 each
34,983
Filed 2017-06-20
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$74,999
+51,724 vol
$1.45 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,270
+51,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,330
+29,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$30,798
+17,400 vol
$1.77 each
67,400
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$54,162
+30,600 vol
$1.77 each
240,600
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$761,100
+430,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$456,660
+258,000 vol
$1.77 each
783,000
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$194,700
+110,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$116,820
+66,000 vol
$1.77 each
148,200
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$274,350
+155,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,610
+93,000 vol
$1.77 each
198,800
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$230,100
+130,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$138,060
+78,000 vol
$1.77 each
278,000
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,330
+29,000 vol
$1.77 each
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$30,798
+17,400 vol
$1.77 each
67,400
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$20,532
+11,600 vol
$1.77 each
90,600
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,330
+29,000 vol
$1.77 each
79,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$92,040
+52,000 vol
$1.77 each
382,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$230,100
+130,000 vol
$1.77 each
330,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$109,740
+62,000 vol
$1.77 each
322,800
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$274,350
+155,000 vol
$1.77 each
260,800
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$77,880
+44,000 vol
$1.77 each
236,200
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$194,700
+110,000 vol
$1.77 each
192,200
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$304,440
+172,000 vol
$1.77 each
1,127,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$761,100
+430,000 vol
$1.77 each
955,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$36,108
+20,400 vol
$1.77 each
281,400
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,270
+51,000 vol
$1.77 each
261,000
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$20,532
+11,600 vol
$1.77 each
90,600
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,330
+29,000 vol
$1.77 each
79,000
Filed 2017-06-13
Tx date 2017-06-13
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$850.00
+500 vol
$1.70 each
81,224
Filed 2017-06-13
Tx date 2017-06-12
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$6,290
+3,700 vol
$1.70 each
80,724
Filed 2017-06-13
Tx date 2017-06-08
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$9,010
+5,300 vol
$1.70 each
77,024
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Vaugeois, Marc
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
1,000
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Khayat, Jacqueline
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
5,000
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-12
Tx date 2017-06-01
$ACST
Acasti Pharma Inc.
Vaugeois, Marc
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-02
Tx date 2017-05-30
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$7,591
+4,500 vol
$1.69 each
71,724
Filed 2017-05-29
Tx date 2017-05-26
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$8,400
+5,000 vol
$1.68 each
67,224
Filed 2017-05-29
Tx date 2017-05-25
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$17,000
+10,000 vol
$1.70 each
62,224
Filed 2017-04-13
Tx date 2017-04-11
$ACST
Acasti Pharma Inc.
Timperio, Michel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options Groupe 11A
52 - Expiration of options
$-157,500
-7,500 vol
$21.00 each
0
Filed 2017-04-13
Tx date 2017-04-11
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-315,000
-15,000 vol
$21.00 each
105,800
Filed 2017-04-13
Tx date 2017-04-11
$ACST
Acasti Pharma Inc.
Huart, Benoît
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
$-105,000
-5,000 vol
$21.00 each
3,600
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$82,500
+50,000 vol
$1.65 each
82,200
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,500
+50,000 vol
$1.65 each
50,000
Filed 2017-03-01
Tx date 2016-07-12
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-01
Tx date 2017-02-28
$ACST
Acasti Pharma Inc.
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
$-14,210.07
-9,051 vol
$1.57 each
51,199
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
97 - Other
$94,200
+60,000 vol
$1.57 each
60,250
Filed 2017-03-01
Tx date 2015-07-14
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$330,000
+200,000 vol
$1.65 each
200,000
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$82,500
+50,000 vol
$1.65 each
120,800
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$82,500
+50,000 vol
$1.65 each
50,000
Filed 2017-02-27
Tx date 2017-02-22
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$76,125
+52,500 vol
$1.45 each
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$76,125
+52,500 vol
$1.45 each
52,500
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+26,250 vol
26,250
Filed 2017-02-27
Tx date 2016-07-12
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$76,125
+52,500 vol
$1.45 each
57,500
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+15,000 vol
15,000
Filed 2017-02-27
Tx date 2016-11-27
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$43,500
+30,000 vol
$1.45 each
30,000
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+25,862 vol
25,862
Filed 2017-02-27
Tx date 2014-06-19
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
Fitzgibbon, Pierre
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
$74,999
+51,724 vol
$1.45 each
52,224
Filed 2017-02-27
Tx date 2017-02-21
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus

+26,250 vol
26,250
Filed 2017-02-27
Tx date 2016-05-12
$ACST
Acasti Pharma Inc.
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-09
Tx date 2016-10-01
$ACST
Acasti Pharma Inc.
Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,500 vol
32,200